18F-fluoromisonidazole positron emission tomography may be applicable in the evaluation of colorectal cancer liver metastasis
- PMID: 30850340
- DOI: 10.1016/j.hbpd.2019.02.008
18F-fluoromisonidazole positron emission tomography may be applicable in the evaluation of colorectal cancer liver metastasis
Abstract
Background: Positron emission tomography (PET) imaging is a non-invasive functional imaging method used to reflect tumor spatial information, and to provide biological characteristics of tumor progression. The aim of this study was to focus on the application of 18F-fluoromisonidazole (FMISO) PET quantitative parameter of maximum standardized uptake value (SUVmax) ratio to detect the liver metastatic potential of human colorectal cancer (CRC) in mice.
Methods: Colorectal liver metastases (CRLM) xenograft models were established by injecting tumor cells (LoVo, HT29 and HCT116) into spleen of mice, tumor-bearing xenograft models were established by subcutaneously injecting tumor cells in the right left flank of mice. Wound healing assays were performed to examine the ability of cell migration in vitro. 18F-FMISO uptake in CRC cell lines was measured by cellular uptake assay. 18F-FMISO-based micro-PET imaging of CRLM and tumor-bearing mice was performed and quantified by tumor-to-liver SUVmax ratio. The correlation between the 18F-FMISO SUVmax ratio, liver metastases number, hypoxia-induced factor 1α (HIF-1α) and serum starvation-induced glucose transporter 1 (GLUT-1) was evaluated using Pearson correlation analysis.
Results: Compared with HT29 and HCT116, LoVo-CRLM mice had significantly higher liver metastases ratio and shorter median survival time. LoVo cells exhibited stronger migration capacity and higher radiotracer uptake compared with HT29 and HCT116 in in vitro. Moreover, 18F-FMISO SUVmax ratio was significantly higher in both LoVo-CRLM model and LoVo-bearing tumor model compared to models established using HT29 and HCT116. In addition, Pearson correlation analysis revealed a significant correlation between 18F-FMISO SUVmax ratio of CRLM mice and number of liver metastases larger than 0.5 cm, as well as between 18F-FMISO SUVmax ratio and HIF-1α or GLUT-1 expression in tumor-bearing tissues.
Conclusions: 18F-FMISO parameter of SUVmax ratio may provide useful tumor biological information in mice with CRLM, thus allowing for better prediction of CRLM and yielding useful radioactive markers for predicting liver metastasis potential in CRC.
Keywords: (18)F-FMISO; Colorectal liver metastases; Heterogeneity; Positron emission tomography.
Copyright © 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Evaluation of [18F]FDG/[18F]FLT/[18F]FMISO-based micro-positron emission tomography in detection of liver metastasis in human colorectal cancer.Nucl Med Biol. 2019 May-Jun;72-73:36-44. doi: 10.1016/j.nucmedbio.2019.07.004. Epub 2019 Jul 11. Nucl Med Biol. 2019. PMID: 31330410
-
Noninvasive evaluation of 18F-FDG/18F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer.Sci Rep. 2018 Dec 13;8(1):17832. doi: 10.1038/s41598-018-36238-x. Sci Rep. 2018. PMID: 30546057 Free PMC article.
-
Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.Abdom Radiol (NY). 2021 Jul;46(7):3227-3237. doi: 10.1007/s00261-021-03015-w. Epub 2021 Mar 13. Abdom Radiol (NY). 2021. PMID: 33712897 Free PMC article.
-
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG.Clin Exp Metastasis. 2023 Dec;40(6):465-491. doi: 10.1007/s10585-023-10231-9. Epub 2023 Sep 8. Clin Exp Metastasis. 2023. PMID: 37682423 Review.
-
Imaging of Colorectal Liver Metastasis.J Gastrointest Surg. 2022 Jan;26(1):245-257. doi: 10.1007/s11605-021-05164-1. Epub 2021 Oct 18. J Gastrointest Surg. 2022. PMID: 34664191 Review.
Cited by
-
Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis.J Transl Med. 2024 Jun 13;22(1):567. doi: 10.1186/s12967-024-05379-1. J Transl Med. 2024. PMID: 38872212 Free PMC article. Review.
-
Limitations of Fluorine 18 Fluoromisonidazole in Assessing Treatment-induced Tissue Hypoxia after Transcatheter Arterial Embolization of Hepatocellular Carcinoma: A Prospective Pilot Study.Radiol Imaging Cancer. 2022 May;4(3):e210094. doi: 10.1148/rycan.210094. Radiol Imaging Cancer. 2022. PMID: 35485937 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous